Patricia Muñoz-Garrido

Author

Biogipuzkoa Health Research Institute

Also Known As

P. Munoz-Garrido, Patricia Munoz-Garrido, Patricia Munoz‐Garrido, Patricia Muñoz-Garrido

Publications

Citations

H-Index

Concepts

All Affiliations

Biogipuzkoa Health Research Institute University of the Basque Country Instituto de Salud Carlos III Ikerbasque Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

About

Patricia Muñoz-Garrido is an author at Biogipuzkoa Health Research Institute specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	188
2	Health Sciences	1	1	75
3	Natural Sciences	1	1	64
4	Biochemistry	1	1	64
5	Gastroenterology	1	1	49

Patricia Muñoz-Garrido

Publications

788

Citations

H-Index

Page 1

	Year	Citations
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms Aitor Esparza-Baquer, Ibone Labiano, Omar Sharif, Gut	2020	112
MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation Oihane Erice, Patricia Muñoz-Garrido, Javier Vaquero, Hepatology	2017	89
Post-translational Regulation of the Type III Inositol 1,4,5-Trisphosphate Receptor by miRNA-506 Meenakshisundaram Ananthanarayanan, Jesús M. Bañales, Mateus T. Guerra, Journal of Biological Chemistry	2014	82
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression Oihane Erice, I. Labiano, Ander Arbelaiz, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Tumor BiologyTgr5 ActivationLiver PhysiologyMedicineBiliary Cancer	2017	75
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease Patricia Muñoz-Garrido, José J.G. Marı́n, María J. Perugorria, Journal of Hepatology PathologyExperimental ModelsFatty Liver DiseaseOxidative StressHepatic Disorders	2015	64
Soluble Adenylyl Cyclase Regulates Bile Salt‐Induced Apoptosis in Human Cholangiocytes Jung‐Chin Chang, Simei Go, Dirk R. de Waart, Hepatology	2016	64
The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma Margherita Correnti, A. Cappon, Mirella Pastore, Liver International	2021	62
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases Aura D. Urribarri, Patricia Muñoz-Garrido, María J. Perugorria, Gut	2014	57
Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy Elisa Lozano, Rocı́o I.R. Macı́as, María J. Monte, Hepatology	2019	54
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study Iván Guerra, Luís Bujanda, Jesús Castro, Journal of Crohn s and Colitis Psc-ibd PatientsMethods Psc-ibd PatientsGastroenterologyPathologyCholangiopathies	2019	49

Page 1